Traders work on the floor of the New York Stock Exchange, February 1, 2013. Credit: Reuters/Brendan McDermid
reuters.com - by P.J. Huffstutter and Tom Polansek - September 3, 2014
(Reuters) - Zoetis Inc has received a conditional license from the U.S. Department of Agriculture for its vaccine against a deadly piglet virus and will begin selling it this month in the United States, the company said on Wednesday.
Shares of Zoetis, the world's largest animal-health company, reached an all-time high of $36.65 and were up 0.7 percent at $35.73 in afternoon trading on the New York Stock Exchange.
With its new vaccine, Zoetis joins a growing push by both the agriculture and pharmaceutical industries to combat the spread of porcine epidemic diarrhea virus (PEDv), which has killed about 13 percent of the U.S. hog herd over the past year.
(READ COMPLETE ARTICLE)
Recent Comments